196 related articles for article (PubMed ID: 38632022)
41. The Changing Landscape of Lymphoma Associated with HIV Infection.
Hübel K
Curr Oncol Rep; 2020 Aug; 22(11):111. PubMed ID: 32803474
[TBL] [Abstract][Full Text] [Related]
42. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
Achenbach CJ; Cole SR; Kitahata MM; Casper C; Willig JH; Mugavero MJ; Saag MS
AIDS; 2011 Mar; 25(5):691-700. PubMed ID: 21160411
[TBL] [Abstract][Full Text] [Related]
43. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.
Antinori A; Cingolani A; Alba L; Ammassari A; Serraino D; Ciancio BC; Palmieri F; De Luca A; Larocca LM; Ruco L; Ippolito G; Cauda R
AIDS; 2001 Aug; 15(12):1483-91. PubMed ID: 11504980
[TBL] [Abstract][Full Text] [Related]
44. Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation.
Cohen YI; Lebel E; Zimran E; Shaulov A; Stepensky P; Grisariu S; Avni B
Transplant Cell Ther; 2023 Aug; 29(8):505.e1-505.e8. PubMed ID: 37160229
[TBL] [Abstract][Full Text] [Related]
45. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
46. High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.
Besson C; Lancar R; Prevot S; Brice P; Meyohas MC; Marchou B; Gabarre J; Bonnet F; Goujard C; Lambotte O; Boué F; Mounier N; Partisani M; Raffi F; Costello R; Hendel-Chavez H; Algarte-Genin M; Trabelsi S; Marchand L; Raphael M; Taoufik Y; Costagliola D
Clin Infect Dis; 2015 Nov; 61(9):1469-75. PubMed ID: 26223997
[TBL] [Abstract][Full Text] [Related]
47. Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas.
Hagemeister FB; Khetan R; Allen P; McLaughlin P; Rodriguez MA; Swan F; Romaguera JE; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():41-6. PubMed ID: 8204519
[TBL] [Abstract][Full Text] [Related]
48. Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy.
Moulignier A; Lamirel C; Picard H; Lebrette MG; Amiel C; Hamidi M; Polivka M; Mikol J; Cochereau I; Pialoux G
Neurology; 2017 Aug; 89(8):796-804. PubMed ID: 28747447
[TBL] [Abstract][Full Text] [Related]
49. [Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan].
Hashimoto Y; Yokohama A; Saitoh A; Nakahashi H; Toyama K; Mitsui T; Koiso H; Saitoh T; Handa H; Uchiumi H; Jinbo T; Murayama K; Tamaki Y; Matsumoto M; Sawamura M; Karasawa M; Murakami H; Hirato J; Nojima Y; Kojima M; Tsukamoto N
Rinsho Ketsueki; 2012 Mar; 53(3):329-36. PubMed ID: 22499050
[TBL] [Abstract][Full Text] [Related]
50. Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort.
Schommers P; Hentrich M; Hoffmann C; Gillor D; Zoufaly A; Jensen B; Bogner JR; Thoden J; Wasmuth JC; Wolf T; Oette M; Müller M; Esser S; Vehreschild JJ; Fätkenheuer G; Wyen C
Br J Haematol; 2015 Mar; 168(6):806-10. PubMed ID: 25403997
[TBL] [Abstract][Full Text] [Related]
51. Malignant lymphomas (ML) and HIV infection in Tanzania.
Mwakigonja AR; Kaaya EE; Mgaya EM
J Exp Clin Cancer Res; 2008 Jun; 27(1):9. PubMed ID: 18577266
[TBL] [Abstract][Full Text] [Related]
52. [Human immunodeficiency virus and lymphoma].
Tazi I; Lahlimi FZ
Bull Cancer; 2021 Oct; 108(10):953-962. PubMed ID: 34246454
[TBL] [Abstract][Full Text] [Related]
53. Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma.
Barta SK; Lee JY; Kaplan LD; Noy A; Sparano JA
Cancer; 2012 Aug; 118(16):3977-83. PubMed ID: 22180164
[TBL] [Abstract][Full Text] [Related]
54. Long-term survival in AIDS-related primary central nervous system lymphoma.
Gupta NK; Nolan A; Omuro A; Reid EG; Wang CC; Mannis G; Jaglal M; Chavez JC; Rubinstein PG; Griffin A; Abrams DI; Hwang J; Kaplan LD; Luce JA; Volberding P; Treseler PA; Rubenstein JL
Neuro Oncol; 2017 Jan; 19(1):99-108. PubMed ID: 27576871
[TBL] [Abstract][Full Text] [Related]
55. AIDS-related lymphomas--potentially curable in the HAART era.
Valencia ME
AIDS Rev; 2006; 8(2):108-10. PubMed ID: 16848278
[No Abstract] [Full Text] [Related]
56. Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.
Besson C; Lancar R; Prevot S; Algarte-Genin M; Delobel P; Bonnet F; Meyohas MC; Partisani M; Oberic L; Gabarre J; Goujard C; Boue F; Coppo P; Costello R; Hendel-Chavez H; Mekerri N; Dos Santos G; Recher C; Delarue R; Casasnovas RO; Taoufik Y; Mounier N; Costagliola D;
AIDS; 2017 Nov; 31(18):2493-2501. PubMed ID: 28926410
[TBL] [Abstract][Full Text] [Related]
57. HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era.
Coutinho R; Pria AD; Gandhi S; Bailey K; Fields P; Cwynarski K; Wilson A; Papanastasopoulos P; Tenant-Flowers M; Webb A; Burns F; Marcus RE; Orkin C; Montoto S; Bower M
AIDS; 2014 Mar; 28(5):689-97. PubMed ID: 24418826
[TBL] [Abstract][Full Text] [Related]
58. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases.
Thompson LD; Fisher SI; Chu WS; Nelson A; Abbondanzo SL
Am J Clin Pathol; 2004 May; 121(5):727-38. PubMed ID: 15151213
[TBL] [Abstract][Full Text] [Related]
59. Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma.
Ge Z; Liu Z; Hu X
World J Surg Oncol; 2016 Mar; 14():85. PubMed ID: 26988370
[TBL] [Abstract][Full Text] [Related]
60. Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.
Moccia AA; Hitz F; Hoskins P; Klasa R; Power MM; Savage KJ; Shenkier T; Shepherd JD; Slack GW; Song KW; Gascoyne RD; Connors JM; Sehn LH
Leuk Lymphoma; 2017 Feb; 58(2):324-332. PubMed ID: 27347845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
